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Abstract
Background: The choice of measure for use as a primary outcome in geriatric research is contingent upon the
construct of interest and evidence for its psychometric properties. The Late-Life Function and Disability Instrument
(LLFDI) has been widely used to assess functional limitations and disability in studies with older adults. The primary aim
of this systematic review was to evaluate the current available evidence for the psychometric properties of the LLFDI.
Methods: Published studies of any design reporting results based on administration of the original version of the
LLFDI in community-dwelling older adults were identified after searches of 9 electronic databases. Data related to
construct validity (convergent/divergent and known-groups validity), test-retest reliability and sensitivity to change
were extracted. Effect sizes were calculated for within-group changes and summarized graphically.
Results: Seventy-one studies including 17,301 older adults met inclusion criteria. Data supporting the convergent/
divergent and known-groups validity for both the Function and Disability components were extracted from 30 and 18
studies, respectively. High test-retest reliability was found for the Function component, while results for the Disability
component were more variable. Sensitivity to change of the LLFDI was confirmed based on findings from 25 studies.
The basic lower extremity subscale and overall summary score of the Function component and limitation dimension of
the Disability component were associated with the strongest relative effect sizes.
Conclusions: There is extensive evidence to support the construct validity and sensitivity to change of the LLFDI
among various clinical populations of community-dwelling older adults. Further work is needed on predictive validity
and values for clinically important change. Findings from this review can be used to guide the selection of the most
appropriate LLFDI subscale for use an outcome measure in geriatric research and practice.
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Background
Accurate assessment of physical functional limitations
and disability is critical for improving access to health
care services for older adults, and for evaluating the
effectiveness of interventions designed to slow or pre-
vent the progression of late-life disability [1,2]. Detecting
meaningful changes in function and disability in older
adults can be challenging, particularly if the outcome
tool is not designed to accurately assess or reflect the
purported change. The choice of outcome measure for
use as a primary outcome in studies with older adults
should be guided by the construct being measured and
evidence for its psychometric properties [3].
Patient-reported measures (PROs) of function and
disability are commonly used in studies of older adults
because of their low cost and convenience. However,
many existing measures were not designed for evaluative
purposes and do not offer a comprehensive assessment
of function or disability based on an explicit theoretical
framework [4]. The Late-Life Function and Disability
Instrument (LLFDI) was developed to overcome some of
these limitations [5,6]. Unlike many other PROs, the
LLFDI comprehensively assesses discrete functional tasks
and operationalizes disability in important life roles
beyond the narrow construct of activities of daily living.
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Nagi’s disablement model [7] and also draws from the
World Health Organization’s International Classification
of Functioning, Disability, and Health (ICF) [8]. The
LLFDI assesses both functional limitations (inability to
perform discrete physical tasks) and disability (inability
to participate in major life tasks and social roles). The
Function component evaluates difficulty in performing
32 physical tasks and is comprised of an overall scale of
function and three subscales: basic lower extremity, ad-
vanced lower extremity and upper extremity. The Disability
component evaluates limitations in and frequency of taking
part in 16 major life activities. The frequency dimen-
sion is comprised of social and personal role subscales
plus an overall scale; the limitation dimension includes
instrumental and management role subscales plus an
overall scale. Raw scores are transformed to scaled
scores (0–100) based on a Rasch model with higher
scores indicating better levels of functioning.
Since its development in 2002, the LLFDI has been fre-
quently used as an outcome measure in geriatric research.
While the original LLFDI development papers [5,6] pro-
vide preliminary support for its validity and reliability,
there is no synthesis of research on its psychometric prop-
erties. The objectives of this systematic review are to
characterize the use of the LLFDI in published studies of
community dwelling older adults and to evaluate the
current available evidence on its psychometric properties.
Methods
We conducted a systematic review of studies reporting
results of the administration of the LLFDI in community-
dwelling older adults. The methodology is based on
PRISMA guidelines [9] for systematic reviews.
Search strategy
Searches were performed by one investigator (MB) in con-
sultation with a librarian. Study identification began with
electronic searching of the ISI Web of Science for studies
citing the two original LLFDI development papers [5,6].
We also searched the following electronic databases
from inception until January 28th 2013: PubMed, Web
of Science, CINAHL, PsychInfo, Google Scholar, JSTOR,
ScienceDirect, WileyInterscience, and EMBASE. Key search
terms were “Late Life Function and Disability Instrument”,
“LLFDI” and “Late life FDI”. Finally, reference lists from
relevant studies were hand-searched to ensure all pos-
sible studies were identified.
Inclusion criteria
Two investigators (MB and CS) independently screened
abstracts of retrieved papers with disagreements resolved
by discussion. Full texts of relevant studies were then
independently assessed by two reviewers (MB and CS)
with disagreements resolved by consultation with a third
reviewer (AJ). Inclusion criteria comprised:
 Types of studies: Any study design reporting results
based on administration of the original version of
the LLFDI.
 Types of participants: Studies including community-
dwelling (non-institutionalized) older adults (mean
age > 60 years).
Studies not published in English and conference abstracts
were excluded.
Data extraction
Two investigators (CS and MP) independently extracted
data into a standardized form. The data extraction form
was pilot tested prior to its use to ensure clarity and
consistency. A third investigator (MB) reviewed and
verified the extracted data for each study.
Data on background characteristics (participants, study
purpose, sample size, design, scales reported) were ex-
tracted for each study. Thereafter, where available, data
related to construct validity (convergent/divergent and
known-groups), reliability (test-retest), and sensitivity to
change (between-group results and within-group ana-
lyses) were extracted.
Data synthesis
Data related to each psychometric property were sum-
marized in tables. By convention, we interpreted a cor-
relation coefficient of <0.3 as weak, 0.3 to 0.7 as
moderate and >0.7 as strong. To facilitate synthesis of the
sensitivity to change findings, where possible, we calcu-
lated Cohen’s effect sizes [10] (mean change/SDbaseline)f o r
within-group analyses. Graphs were created to visually
depict the effect size results by scale. Values of 0.20, 0.50,
and 0.80 have been used to represent small, moderate and
large effect sizes, respectively [10].
Results
Search results
The study selection process is outlined in Figure 1. Of a
possible 940 studies, 71 were included [5,6,11-79]. Back-
ground characteristics of each study are summarized in
Table S1 of Additional file 1. In total, the LLFDI was ad-
ministered to 17,301 older adults with individual study
sample sizes ranging from 11 [28] to 1,441 [27]. The ma-
jority of studies were conducted in the United States,
however the LLFDI has also been used in Canada
[21,22,24,32,48,58-60,64], Israel [37,51,52,72], Australia
[17,23,29], New Zealand [39,67], Iceland [12,13], and the
United Kingdom [24]. The study designs included cross-
sectional, cohort and clinical trials. Many studies focused
on community-dwelling older adults in general, however
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represented including: pre-frail and mobility limited older
adults [14,15,20,23,29,33,36,47,66,67,70,75,76], various mus-
culoskeletal populations (osteoarthritis, total joint replace-
ment, fibromyalgia) [11,21,22,27,32,42,59,60,65,69-71,74,78],
cancer [24,48,55,58,79], psychological disorders (depression,
anxiety) [38,46,61,73], stroke [18,45,57], veterans [18,54],
urinary incontinence [37] and coronary heart disease [44].
The mean age across studies was 73 years (range 62 to
102). Most commonly, the overall function score of the
Function component and limitation and frequency di-
mensions of the Disability component were used.
Convergent/divergent validity
Data related to convergent/divergent validity of the
LLFDI, that is, the degree to which LLFDI compo-
nents and subscales correlated with measures of
conceptually related (convergent) or unrelated (diver-
gent) constructs, were extracted from 30 studies
[12,13,15,17,25,27-29,32,33,36-38,42,44,45,47,49,51,52,56,
61-63,65,66,68,71,72,74]. We hypothesized that moder-
ate to strong correlations would be seen for variables
theoretically related to function and disability (i.e.,
health status, function, mobility, balance and physical
activity measures) while weak to moderate correlations
would be observed for those variables less related the-
oretically to function and disability (e.g., biochemical
markers). The correlation coefficients reported in the
text below represent the range of coefficients observed
between the various scales of the LLFDI and the related
measure of interest. Detailed results for each individual
study (correlation coefficients and statistical significance
for each subscale) are outlined in Table S2 of Additional
file 1.
Function component
The Function component of the LLFDI consistently
demonstrated moderate to strong correlations with other
self-report health-status and multi-component function
scales including the 10-item Physical Functioning Scale
of the SF-36 (PF-10) (r = 0.51 to 0.85) [25], Activities of
Daily Living scale (r = −0.53 to −0.68) [28], Bradburn
Affect Balance Scale (BABS) (r = 0.51 to 0.80) [28],
Multidimensional Fatigue Inventory (MFI) (r = 0.46 to
0.64) [28], self-rated health (r = 0.68 to 0.70) [28],
RAND-36 physical functioning subscale (r = 0.83) [44]
and the London Handicap Scale (LHS) (r = 0.65) [44].
Moderate to strong correlations were also seen between
LLFDI Function and single-concept mobility scales such
as the Modified Gait Efficacy Scale (mGES) (r = 0.88)
[56] and Physical Activity Scale for the Elderly (PASE)
(r = 0.56) [44].
The LLFDI Function component demonstrated moderate
to strong correlations with performance-based measures of
Figure 1 Study identification process.
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Performance Battery (SPPB) (r = 0.29 to 0.67) [15,68,71]
and Timed Up and Go (TUG) (r = −0.34 to −0.71)
[51,52,66]. Moderate to strong correlations were also
observed between LLFDI Function and single-concept
performance-based mobility measures such as objectively
measured physical activity (r = −0.30 to −0.70) [28], the
Figure-of-8 Walk Test (F8W) (r = −0.45) [33], Berg
Balance Scale (BBS) (r = 0.30 to 0.75) [51,52,66], walking
speed (r = −0.55 to −0.57) [44], six-minute walking test
(6MWT) (r = 0.62) [44], sit-to-stand test (r = −0.56) [44]
and 400-meter walk (r = 0.26 to 0.73) [68,71].
In general, evidence for convergent validity was stron-
gest for the overall function scale followed by the two
lower-extremity sub-scales. The upper extremity sub-
scale showed the lowest associations with other mea-
sures of function; however the latter primarily consisted
of lower-extremity tasks. Evidence for divergent validity
was shown by the weaker to moderate correlations
found between the LLFDI Function component and less
theoretically related constructs (neighbourhood walk-
ability scores, Acylcarnitine factor scores, Vitamin D
metabolites, B12, folate, Tangible Social Support Scale,
age, BMI, income, education) [17,49,63,72,74].
Disability component
The Disability component demonstrated moderate cor-
relations with other self-report health status and multi-
component functional scales including the LHS (r = 0.47
to 0.66) [25,44], PF-10 (0.35 to 0.47) [25,38], Rand-36
physical functioning subscale (r = 0.38 to 0.68) [44],
Hamilton Rating Scale for Depresssion-17 (r = −0.38)
[38] and Anxiety [38,61] (r = −0.30 to −0.41), Western
Ontario and McMasters Universities Osteoarthritis Index
(WOMAC) (r = −0.23 to −0.47) [65] and the Center for
Epidemiologic Studies Depression Scale (r = −0.38
to −0.56) [65]. Moderate to strong correlations were also
seen between LLFDI Disability and single-concept mobil-
ity scales such as the PASE (r = 0.54 to 0.56) [44] and
mGES (r = 0.32 to 0.63) [56].
Weak to moderate correlations were found between
the Disability component and performance-based mea-
sures of multi-component function including the SPPB
(r = 0.16 to 0.37) [68] and TUG (r = −0.06 to −0.30)
[51,52]. Moderate to strong correlations were also ob-
served between LLFDI Disability and single-concept
performance-based mobility measures such as the F8W
(r = −0.26) [33], BBS (r = 0.15 to 0.35) [51,52], walking
speed (r = 0.01 to −0.33) [44], 20-meter walk (r = 0.24 to
0.37) [65] and 400-meter walk tests (r = 0.20 to 0.44) [68].
In general, the limitation dimension showed greater
associations with the self-report and performance-based
measures than the frequency dimension. Evidence for
divergent validity was shown by the generally weak cor-
relations between the LLFDI Disability component and
less theoretically related constructs (neighbourhood
walkability scores, Vitamin D metabolites, B12, folate,
coping strategies, pain, body fat percentage, BMI)
[17,27,37,65,72].
Known-groups validity
Data related to know-groups validity of the LLFDI, that
is, the degree to which scores of the Disability and
Function components distinguished between groups
known to differ, were extracted from 18 studies
[5,6,27,29,30,36-38,40,47,48,51,52,61,68,69,72,73] and are
shown in Table 1. Discrimination between groups was
considered if comparisons of the LLFDI between different
subgroups of an independent measure or external param-
eter achieved statistical significance.
Function component
The LLFDI Function component discriminated between
groups based on residence status [29], gender [30], de-
pression [30], urinary incontinence [37], level of function
and mobility limitation [5,68], physical activity levels [40],
gait speed [47], fall status [51], walking exertion [36], cane
use [52] and sit-to-stand performance [69]. Evidence for
known-groups validity was strongest for the overall func-
tion score followed by the two lower-extremity scales.
Disability component
The Disability component of the LLFDI discriminated be-
tween groups based on gender [29], race [73], level of
function and mobility limitation [5,68], depression [38],
anxiety [61], cane use [52], gait speed [47] and walking ex-
ertion [36]. Unlike the Function component, the Disability
component did not discriminate between groups based on
residence status [29], urinary incontinence [37] or fall sta-
tus [51]. Evidence for known-groups validity was strongest
for the limitation dimension and associated instrumental
role domain compared to the frequency dimension and
associated domains.
Reliability
Only three studies [5,6,52] included information related
to the test-retest reliability of the LLFDI. Short-term
stability of the English version of the LLFDI was only
examined in the original development papers.
Function component
Intra-class correlation coefficients (ICCs) for the Function
component were 0.96 for overall function, 0.97 for
advanced lower-extremity, 0.98 for basic lower extremity
and 0.91 for upper extremity (n = 15, 12-day testing inter-
val) [5]. For the Hebrew version examined by Melzer et al.
[52], test-retest ICCs were 0.9, 0.86, 0.77 and 0.79 for
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Study Scale(s) Function component Disability component
Foster et al. 2011 [27] Disability (IR) Lower body obesity vs. central obesity group:
No between-group differences in men or
women for IR.
Gibson et al. 2010 [29] Function (overall)
Disability (FREQ, LIM)
Community dwellers vs. retirement dwellers
and males vs. females:
Overall function discriminated between
both groups (p = 0.015 and p < 0.001,
respectively).
Community dwellers vs. retirement dwellers:
No between-group differences in FREQ or LIM.
Males vs. females:
FREQ (p = 0.013) discriminated between
groups.
Gitlin et al. 2012 [30] Function (overall) Female vs. male and depressed vs.
non-depressed:
Overall function differed in both groups
(p <0.01 and p <0.001, respectively).
Haley et al. 2002 [5] Function (overall, UE,
BLE, ALE)
Functional limitation groups measured by the
PF-10:
Overall function and ALE discriminated
between severe vs. moderate, moderate vs.
slight and slight vs. none (all p < 0.0167).
BLE and UE discriminated between severe vs.
moderate and moderate vs. slight
(all p <0.0167).
Jette et al. 2002 [6] Disability (FREQ, LIM,
SR, PR, IR, MR)
Functional limitation groups measured by the
PF-10:
FREQ, SR, LIM and IR all discriminated between
severe vs. moderate, moderate vs. slight and
slight vs. none groups (all p <0.0167). PR
discriminated between moderate vs. slight
(p < 0.0167).
Julius et al. 2012 [36] Function (overall, BLE,
ALE) Disability (LIM)
No exertion during walking vs. some exertion
during walking:
No exertion during walking vs. some exertion
during walking:
Overall function (p = 0.011), BLE (p = 0.012)
and ALE (p = 0.022) all discriminated between
groups.
LIM (p = 0.024) discriminated between
groups.
Kafri et al. 2012 [37] Function (overall, UE,
BLE, ALE) Disability
(LIM, FREQ, IR, MR,
SR, PR)
Urgency urinary incontinence (UUI) vs.
age-matched controls:
Lower overall function (p < 0.001) and ALE
(p <0.001) in those with UUI.
Urgency urinary incontinence (UUI) vs.
age-matched controls:
No differences between groups in Disability.
Karp et al. 2009 [38] Disability (LIM, FREQ) Not depressed vs. depressed:
Lower FREQ and LIM scores in depressed
(both p <0.001).
Kerr et al. 2012 [40] Function (overall) <30 min physical activity vs. 30+min physical
activity:
Function differed between groups (p = 0.002).
<30 min outdoors vs. 30+ min outdoors:
Function differed between groups (p = 0.007).
Li et al. 2012 [47] Function (overall)
Disability (LIM, FREQ)
High habitual gait speed (HGS) vs. moderate vs. low:
Function (overall) (p <0.001) discriminated between
groups.
High habitual gait speed (HGS) vs. moderate
vs. low:
LIM (p < 0.001) discriminated between groups.
Lowe et al. 2009 [48] Function (BLE, UE, ALE) Walking≥30 min/day vs. walking <30 min/day and
walking≥60 min/day vs. walking <60 min/day:
Trend for higher ALE in subjects who walked
≥ 30 min/day (p = 0.17) and in≥60 min/day
group (p = 0.10).
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upper extremity scales, respectively (n = 55, 10–14 day
test interval).
Disability component
Test-retest ICCs for the Disability component were 0.68 for
the frequency dimension, 0.75 for the social role domain,
0.63 for the personal role domain, 0.82 for the limitation di-
mension, 0.83 for the instrumental role domain, and 0.44
for the management role domain (n = 15, 12 day interval)
[6]. For the Hebrew version, ICCs were, 0.8, 0.83, 0.63,
0.69, 0.72 and 0.69 for each of the respective scales as listed
above (n = 55, 10–14 day interval) [52].
Sensitivity to change
Data on sensitivity to change were extracted from
25 studies [11,14,18-20,22-24,38,39,44,46,53-55,57-59,
64,66,67,70,75,76,79]; 18 were RCTs [11,14,18-20,23,39,
46,53-55,57,64,66,67,75,76,79],2w e r ec o h o r ts t u d i e s
[22,59], 3 were single-group studies [38,58,70] and 1 was
a cross-over trial [24]. One study was cross-sectional [44]
but was included as it contained information on minimal
detectable change (MDC). A detailed description of the in-
dividual study results is provided in Table S3 of Additional
file 1. To facilitate interpretation of results, we classified
studies as either 1) positive trials (i.e., RCTs in which there
was a between-group difference in favor of the intervention
in 1 primary or >2 secondary outcomes) 2) neutral trials or
3) single-group analyses (for cohort studies or single-group
interventions). Among the 12 positive RCTs [14,18,19,39,
46,53-55,57,75,76,79], between-group differences in favor of
the intervention group were detected by the LLFDI in 9
studies [18,19,39,46,53-55,57,76].
Function component
A summary of the calculated effect sizes (ES) for the
LLFDI Function component can be found in Figure 2.
Eleven RCTs were classified as positive trials [14,18,
19,39,53-55,57,75,76,79]; all interventions included some
type of exercise intervention with the exception of 1 trial
Table 1 Known-groups validity of the Late-Life Function and Disability Instrument (Continued)
Melzer & Kurz 2009 [51] Function (BLE, UE, ALE)
Disability (LIM, FREQ)
Non-fallers vs. one-time fallers vs. recurrent
fallers:
Non-fallers vs. one-time fallers vs. recurrent
fallers:
Overall function (p = 0.04) and BLE (p = 0.03)
discriminated between recurrent fallers and
non-fallers.
No differences between groups.
Melzer et al. 2007 [52] Function (overall, UE,
BLE, ALE), Disability
(FREQ, LIM, SR, PR,
IR, MR)
Cane vs. non-cane (NC) users: Cane vs. non-cane (NC) users:
Overall function (p = 0.001), UE (p = 0.004),
BLE (p = 0.001), ALE (p = 0.003) all discriminated
between groups.
LIM (p < 0.001), IR (p < 0.001), MR (p = 0.001),
FREQ (p = 0.047) and SR (p = 0.046) all
discriminated between groups. Trend for a
difference in PR (p = 0.16).
Porensky et al. 2009 [61] Disability (FREQ, LIM) Controls vs. those with Generalized Anxiety
Disorder (GAD) without comorbitidy (CM) vs.
those with GAD and CM:
Both FREQ and LIM discriminated across
groups (p < 0.001).
Post-hoc analysis showed FREQ and LIM
differed in both GAD groups vs. controls.
Sayers et al. 2004 [68] Function (overall, UE,
BLE, ALE) Disability
(LIM, FREQ)
Mobility limited vs. non-mobility limited based
on 400 m walk:
Overall function, UE, BLE, ALE all discriminated
between groups (all p <0.01).
Mobility limited vs. non-mobility limited based
on 400 m walk:
LIM and FREQ both discriminated between
groups (both p <0.01).
Segal et al. 2013 [69] Function (ALE) High vs. moderate vs. low functioning based on
chair-stand test:
Men in the high-functioning group reported
higher ALE than those in the moderate and
low-functioning groups (p = 0.004).
Shahar et al. 2009 [72] Function (overall, BLE)
Disability (LIM)
Fallers vs. non-fallers: Fallers vs. non-fallers:
Trend for difference in overall function
(p = 0.06) and BLE (p = 0.16).
No difference in LIM between groups.
Sriwattanakomen et al.
2010 [73]
Disability (LIM, FREQ) Black vs. white:
LIM greater in blacks vs. whites (p = 0.02).
FREQ not different between groups.
BLE, Basic lower extremity scale; ALE, Advanced lower extremity scale; UE, Upper extremity scale; FREQ, Frequency dimension; LIM, Limitation dimension; SR, Social
role domain; PR, Personal role domain; IR, Instrumental role domain; MR, Management role domain.
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extremity scale showed the greatest sensitivity to change
(mean ES 0.45, range 0.02 to 0.84, n = 7) [18,39,53,
55,57,76,79], followed by overall function (mean ES 0.40,
range 0.04 to 0.74, n = 8) [14,19,39,53,54,57,75,76],
advanced lower extremity (mean ES 0.33 range −0.02 to
0.78, n = 7) [18,39,53,55,57,76,79], and upper extremity
(mean ES 0.21, range −0.19 to 0.57, n = 5) [18,39,53,
57,79] scales (see Table 2). Of note, in the positive
Morey et al. trial [55], although the ES for basic and
-1 -0.8 -0.5 -0.2 0 0.2 0.5 0.8 1
Segal & Wallace 2012
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Daniel 2012
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Richardson et al. 2010
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Travison et al. 2011
Ouellette et al. 2004
Morey et al. 2009b
Morey et al. 2009a
Melzer & Oddson 2012
Keogh et al. 2012
Clemson et al. 2012
Chumbler et al. 2012
Bean et al. 2009
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Neutral RCTs
Single group
Effect Size
Overall Function
Basic Lower Extremity
Advanced Lower Extremity
Upper Extremity
Figure 2 Effect sizes for the Function component of the Late Life Function and Disability Instrument.
Table 2 Summary of mean effect sizes for the Late-Life Function and Disability Instrument in positive randomized
controlled trials
Component Subscale Mean effect size (range) No of studies, total sample size
Function Overall 0.40 (0.04 to 0.74) 8, 487
Basic lower extremity 0.45 (0.02 to 0.84) 7, 466
Advanced lower extremity 0.33 (−0.02 to 0.78) 7, 466
Upper extremity 0.21 (−0.19 to 0.57) 5, 124
Disability Limitation dimension 0.35 (−0.10 to 1.2) 7, 444
Instrumental role 0.83 (0.47 to 1.28) 3, 66
Management role 0.55 (0.48 to 0.62) 2, 43
Frequency dimension 0.32 (0.13 to 0.67) 4, 300
Social role 0.36 (0.01 to 0.71) 2, 43
Personal role 0.30 (0.19 to 0.40) 2, 43
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group were negligible (0.02 and −0.02, respectively), re-
sults were favourable against the backdrop of functional
decline in the control group. Among the neutral trials
[11,23,64,67] (n = 4), ES estimates ranged from −0.04 [64]
to 0.17 [11]. Within the single-group analyses [20,58,70]
(n = 3), a Wii-Fit rehabilitation program [20] was associ-
ated with the greatest ES for overall function (0.47), while
ES after a resistance training program among cancer sur-
vivors [58] ranged from 0.13 (advanced lower extremity)
to 0.21 (basic lower extremity), and was 0.20 for basic lower
extremity after an aquatic power training program [70].
Information on meaningful change was available from
two studies. In a cross-sectional study of older adults
with chronic heart failure [44] the MDC95 was estimated
at 4.3 points for overall function. In the 6-month RCT
of testosterone administration in older men with mobil-
ity limitation [75], the minimal important difference for
overall function (calculated using patient-reported global
rating of change) was 2.7 points.
Disability component
Figure 3 shows a summary of effect sizes for the Disability
component. Seven RCTs were classified as positive trials
[18,19,46,54,57,76,79]; 6 included some form of exercise
intervention and 1 [46] was a trial of antidepressant
therapy. The limitation dimension was associated a
higher ES (mean ES 0.35, range −0.10 to 1.2, n = 7)
[18,19,46,54,57,76,79] than the frequency dimension
(mean ES 0.32, range 0.13 to 0.67, n = 4) (see Table 2)
[18,19,54,57]. Among the domain roles, the highest ES
was for instrumental (mean ES 0.83, range 0.47 to 1.28,
n = 3) [18,57,76], followed by management (mean ES
0.55, range 0.48 to 0.62, n = 2) [18,57], social (mean ES
0.36 range 0.01 to 0.71, n = 2) [18,57] and personal
(mean ES 0.30, range 0.19 to 0.40, n = 2) [18,57] roles.
Effect sizes for the neutral RCTs [11,23,64] (n = 3) were
all <0.30 except for the limitation dimension in the Tai
Chi trial [11] (ES 0.60). For the single-group analyses
[20,22,38,59] (n = 4), ES ranged from 0.12 (frequency
dimension) and 0.46 (limitation dimension) after a Wii-
-1 -0.8 -0.5 -0.2 0 0.2 0.5 0.8 1
Positive RCTs
Neutral RCTs
Single group
Effect Size
Frequency Dimension
Social Role Domain
Personal Role Domain
Limitation Dimension
Instrumental Role Domain
Management Role Domain
Morey et al. 2009b
Lenze et al. 2009
Perrucio et al. 2010
Karp et al. 2009
Davis et al. 2011
Daniel 2012
Richardson et al. 2010
Day et al. 2012
Adler 2007
Winters-Stone et al. 2012
VanSwearingen et al. 2011
Ouellette et al. 2004
Clemson et al. 2012
Chumbler et al. 2012
Figure 3 Effect sizes for the Disability component of the Late Life Function and Disability Instrument.
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http://www.biomedcentral.com/1471-2318/14/12fit rehabilitation intervention [20] to 0.67 (frequency
dimension) and 1.6 (limitation dimension) in the cohort
study of joint replacement surgery [22].
Information on meaningful change was only available
from 1 study. In the cross-sectional study of older adults
with chronic heart failure [44] the MDC95 was estimated
at 7.8 points for the frequency dimension and 16.7 for
the limitation dimension.
Discussion
Since its conception in 2002, the LLFDI has been used
as an outcome measure in over 70 studies including
more than 17,000 community-dwelling older adults. Evi-
dence for its psychometric properties has been demon-
strated across a wide range of older clinical populations
and contexts. The choice of LLFDI sub-scale for use in
individual studies should depend on the construct of
interest and evidence for relevant psychometric properties
in the most applicable population. Results of this review
can be used by researchers to guide future decisions
regarding the use of the LLFDI as an outcome measure
for clinical research in community-dwelling older adults.
The construct validity of both the Function and Disability
components of the LLFDI was well-supported by the
evidence found in this review. We noted moderate to
strong convergent validity between the Function compo-
nent and well-validated self-report and performance-based
measures of function such as the PF-10 and SPPB. In
addition, while there is no accepted gold-standard measure
of disability, the Disability component was moderately
associated with general health status measures such as the
L H Sa n dR A N D - 3 6a sw e l la sw i t hm a n yc o m m o n l yu s e d
self-report and performance-based measures of function.
The LLFDI also showed strong known-groups validity with
both components discriminating between groups based on
various functional, demographic and medical categories.
Our review did not reveal any studies evaluating the use of
LLFDI measures of Function or Disability for predicting
institutionalization or mortality, highlighting the need for
further research on the predictive validity of the LLFDI.
Only three studies [5,6,52] investigated the test-retest
reliability of the LLFDI and two were the original devel-
opment papers. While very high reliability scores (ICCs
0.91-0.98) were reported for all Function scales, a wider
range of reliability was reported within the Disability
component (ICCs 0.44-0.82). In general, the Disability
limitation and frequency dimensions showed moderate
to high test-retest reliability with the limitation dimen-
sion and instrumental role domain showing the best
reproducibility. The management role domain had the
lowest reliability, likely due to the limited 4-item pool of
this scale. Larger studies on test-retest reliability of the
LLFDI would be helpful, especially in light of the lower
reproducibility reported for the Disability component.
PROs are often thought to have limited capacity for
detecting change given their breadth of measurement and
vulnerability to external influences [1,80,81]. In this review,
sensitivity to change of the LLFDI was confirmed based on
findings from 25 studies. Most scales demonstrated small
to moderate effect sizes in positive trials and in cohort
studies in which the participants underwent a change in
health status. In particular, we noted larger effect sizes for
the basic lower extremity scale and summary score of the
Function component as well as for the limitation dimen-
sion of the Disability component as compared to the other
LLFDI scales. These results should be considered when
selecting the most appropriate scale for use in clinical tri-
als and longitudinal studies with community dwelling
older adults. Only one study [75] attempted to define a
clinically meaningful difference for the LLFDI, however
this study included only men was based on a testosterone
intervention. There remains a need for further work to
determine the increments of change on the LLFDI that
are clinically meaningful.
Our findings are subject to several limitations. A qual-
ity assessment was beyond the scope of this review and
very few studies were designed specifically to measure
psychometric properties of the LLFDI. We were unable
to perform any formal meta-analysis due to the hetero-
geneity in study outcomes, clinical populations and de-
sign. While every attempt was made to identify relevant
studies, it is possible that some studies were missed.
Finally, our results are only applicable to the original
version of the LLFDI administered in community-dwelling
older adults. An abbreviated version of the instrument [50]
has been developed as well as a computer adaptive ver-
sion [82] and the psychometric properties of these in-
struments should be considered separately.
Conclusions
In summary, we have conducted a systematic review of
the use of the LLFDI and evidence for its psychometric
properties based on 71 published studies. While we have
shown extensive data supporting the instrument’sc o n -
struct validity and sensitivity to change among various
clinical populations of community-dwelling older adults,
further work is needed to determine the LLFDI’s predict-
ive validity and values for clinically meaningful change.
Results from this review can be used to inform the selec-
tion of the most appropriate LLFDI component and sub-
scale for use as an outcome measure in geriatric research.
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